ロード中...
CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma
Drug resistance is a significant obstacle in cancer treatment and therefore a frequent subject of research. Developed or primary resistance limits the treatment success of inhibitors of the B cell receptor (BCR) pathway in mantle cell lymphoma (MCL) patients. Recent research has highlighted the role...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833745/ https://ncbi.nlm.nih.gov/pubmed/29367645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0157-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|